The seismic shifts in the reimbursement mechanisms for orthotics and prosthetics have changed the complexion of the industry. Some of the regulatory changes have been a shot in the arm for the space and provide practitioners the clarity they need to improve reimbursement and comply with regulatory measures
Recently, CMS issued the CY 2024 Home Health Prospective Payment final rule ("Final Rule"), which includes a provision formalizing the definition of a "brace" or "orthosis" within federal regulations.
Regarding the definition of a brace, CMS has adopted its proposal to amend federal Medicare regulations to explicitly define a "brace." Currently, this term is defined in the Medicare Benefit Policy Manual (MBPM), which serves as guidance without the weight of regulations. The final rule now defines braces as "rigid and semi-rigid devices used to support a weak or deformed body member or restrict or eliminate motion in a diseased or injured part of the body." This solidifies the definition of an orthosis.
The rule further clarifies that devices with powered features designed to aid traditional bracing functions are classified as braces. Specifically, powered upper extremity and lower extremity exoskeleton devices will be categorized as orthotics. This decision represents a significant advancement for patients and providers in the O&P field and is anticipated to facilitate Medicare coverage of advanced powered orthoses.
Improving reimbursement for powered extremity bracing involves advocating for policies that recognize the clinical and functional benefits of these advanced devices.
Achieving fair reimbursement for powered extremity bracing necessitates a concerted effort to demonstrate the significant clinical and functional advantages these devices offer. These advanced orthotic solutions not only enhance mobility and independence for patients but also contribute to improved health outcomes and overall quality of life.
In closing, enhancing reimbursement for powered extremity bracing requires a comprehensive approach that emphasizes clinical benefits, patient outcomes, technological advancements, and economic considerations. By advocating for policies that recognize these factors, we can ensure that patients have access to the most effective orthotic solutions, ultimately improving their quality of life and reducing overall healthcare costs.